# Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases

> **NCT02922699** · PHASE4 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 120 (actual)

## Conditions studied

- GERD

## Interventions

- **DRUG:** OMEZ 40
- **DRUG:** OMEZ 80

## Key facts

- **NCT ID:** NCT02922699
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02922699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02922699, "Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02922699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*